Does autologous blood transfusion during liver transplantation for hepatocellular carcinoma increase risk of recurrence?

Table 3 Univariate analysis for predictors of recurrence

	Total	5-yr survival (%)	Median survival (mo)	Univariate analysis P
Overall	158	83.3	-	-
Age (≥ 60 yr)	-	-	-	0.319
Male gender	-	-	-	0.410
BMI (≥ 28)	-	-	-	0.166
Pre-op AFP (≥ 100 mg/dL)				0.001
Yes	19	59.4	84.5
No	129	85	-
Cirrhosis	-	-	-	0.163
Alcohol related	-	-	-	0.207
Hepatitis B infection	-	-	-	0.911
Hepatitis C infection	-	-	-	0.568
Others	-	-	-	0.794
Blood type	-	-	-	0.912
Rhesus	-	-	-	0.494
MELD (≥ 15)	-	-	-	0.694
Radiofrequency	-	-	-	0.758
Chemoembolization	-	-	-	0.133
Tumor alcoholization	-	-	-	0.373
Graft/body % (≥ 2)	-	-	-	0.605
Number of lesions (> 3)	-	-	-	0.496
Largest lesion mm (≥ 30)	-	-	-	0.429
Edmond-Steiner degree				0.0162
III-IV	88	73	84.5
0-II	59	94.3	-
Vascular invasion				0.071
Yes	26	74.8	84.5
No	132	86.3	-
Microsatellite lesions				0.007
Yes	26	-	-
No	132	86.5	-
Cholangiocarcinoma	-	-	-	0.375
IBS				0.953
Yes	122	85	84.5
No	36	78.8	-

BMI: Body mass index; AFP: Alpha-feto protein; IBS: Intraoperative blood salvage; MELD: Model of End-Stage Liver Disease.